Safety, tolerability and pharmacokinetics of fesoterodine after co-treatment with the potent cytochrome P450 3A4 inhibitor ketoconazole
Sachse R1, Cawello W1, Horstmann R1 1. Department of Clinical Pharmacology, Schwarz Biosciences, Monheim, Germany
|
|
Abstract 586
|
|
|
Read By Title:
Scientific Non Discussion Abstract Session 21
|
|
|